Vaccines for the New Millennium Act of 2005
Latest action · Sep 14, 2005 Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043)
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 14, 2005
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Vaccines for the New Millennium Act of 2005 - Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries.
Directs the Secretary of the Treasury to: (1) enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides; and (2) establish in the Treasury the Lifesaving Vaccine Purchase Fund.
Amends the Internal Revenue Code to establish business credits for: (1) vaccine research related to HIV/AIDS, malaria, tuberculosis, or certain infectious diseases afflicting developing countries; and (2) certain sales of lifesaving vaccines to nonprofit organizations, or to foreign governments or instrumentalities for distribution in developing countries.
Amends the Small Business Act to: (1) direct the Small Business Administration (SBA) to establish a four-year pilot program to encourage the development of such vaccines and microbicides, including program outreach activities; and (2) provide Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) funding for such vaccines and microbicides.
Cosponsors 6
Members who signed on, in the order they did. Signatures ran from Sep 14, 2005 to May 12, 2006, with 1 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IN | Richard G. Lugar | Original | Sep 14, 2005 |
| D-DE | Joseph R. Biden Jr. | Oct 17, 2005 | |
| D-IL | Richard J. Durbin | Dec 12, 2005 | |
| D-CO | Ken Salazar | Feb 2, 2006 | |
| D-WA | Patty Murray | May 9, 2006 | |
| D-WA | Maria Cantwell | May 12, 2006 |
Actions 3
Everything that happened, newest first.
- Sep 14, 2005Introduced in Senate
- Sep 14, 2005Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043)
- Sep 14, 2005Sponsor introductory remarks on measure. (CR S10039-10040)
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 3781 | Vaccines for the New Millennium Act of 2005 | Identical bill | Oct 17, 2005 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
- AIDS (Disease)
- Child health
- Clinical trials
- Commerce
- Communicable diseases
- Competition
- Congress
- Congressional reporting requirements
- Contracts
- Corporation taxes
- Developing countries
- Development credit institutions
- Dispute settlement
- Drug approvals
- Drug industry
- Drugs
- Economics and Public Finance
- Families
- Foreign Trade and International Finance
- Gifts
- Government contractors
- Government Operations and Politics
- Government procurement
- Government trust funds
- Governmental investigations
- Health
- Human immunodeficiency viruses
- Income tax
- Intellectual property
- International Affairs
- International agencies
- International cooperation in science
- Law
- Liability (Law)
- Malaria
- Medical malpractice
- Medical technology
- Negotiations
- Nongovernmental organizations
- Nonprofit organizations
- Patents
- Pharmaceutical research
- Preventive medicine
- Prices
- Public-private partnerships
- Research and development
- Research and development tax credit
- Research grants
- Science, Technology, Communications
- Small business
- Social Welfare
- Tax credits
- Tax refunds
- Taxation
- Technology transfer
- Treaties
- Tuberculosis
- United Nations
- Vaccination
- Vaccines
- World health
Text 1
Each version as it was printed, newest first.
- Sep 14, 2005Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.